Pillstats
Rx only · Solution · Oral

Sirolimus

Sirolimus

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)35302
US makers9 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.51$3.02$4.53$6.04Dec 2025Apr 2026Jul 2026
$4.908
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
9
Active US suppliers
22%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.8K4.3K5.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.7K
Rx · 2026 Q1
307K
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager1SUPPLYING
Novadoz Pharmaceuticals LLCunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING
Rising Pharma Holdings, Inc.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
VistaPharm, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 3, 2022
    RECALLRecall (Class III): Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 M…

    Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint. — Recalling firm: Apotex Corp. — Nationwide in the USA